Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Parenteral Nutrition Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

Published : Dec 2022

Report ID: ARC1282

Pages : 250

Format : Parenteral Nutrition Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Parenteral Nutrition Market

1.1. Definition and Scope

1.1.1. Definition of Parenteral Nutrition

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Parenteral Nutrition Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Parenteral Nutrition Market By Nutrient Type

1.2.3. Parenteral Nutrition Market By Consumer

1.2.4. Parenteral Nutrition Market By End-use

1.2.5. Parenteral Nutrition Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data End-use

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Parenteral Nutrition Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Parenteral Nutrition Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Parenteral Nutrition Market By Nutrient Type

4.1. Introduction

4.2. Parenteral Nutrition Revenue By Nutrient Type

4.2.1. Parenteral Nutrition Revenue (USD Million) and Forecast, By Nutrient Type, 2018-2030

4.2.2. Carbohydrates

4.2.2.1. Carbohydrates Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3. Trace Elements

4.2.3.1. Trace Elements Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.4. Single Dose Amino Acid Solution

4.2.4.1. Single Dose Amino Acid Solution Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.5. Parenteral Lipid Emulsion

4.2.5.1. Parenteral Lipid Emulsion Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.6. Vitamins & Minerals

4.2.6.1. Vitamins & Minerals Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 5. Parenteral Nutrition Market By Consumer

5.1. Introduction

5.2. Parenteral Nutrition Revenue By Consumer

5.2.1. Parenteral Nutrition Revenue (USD Million) and Forecast, By Consumer, 2018-2030

5.2.2. Children and Newborns

5.2.2.1. Children and Newborns Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3. Adult

5.2.3.1. Adult Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 6. Parenteral Nutrition Market By End-use

6.1. Introduction

6.2. Parenteral Nutrition Revenue By End-use

6.2.1. Parenteral Nutrition Revenue (USD Million) and Forecast, By End-use, 2018-2030

6.2.2. Hospitals

6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.3. Homecare

6.2.3.1. Homecare Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.4. Clinics

6.2.4.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.5. Others

6.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Parenteral Nutrition Market By Country 

7.1. North America Parenteral Nutrition Market Overview

7.2. U.S.

7.2.1. U.S. Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

7.2.2. U.S. Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

7.2.3. U.S. Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

7.3. Canada

7.3.1. Canada Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

7.3.2. Canada Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

7.3.3. Canada Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Parenteral Nutrition Market By Country

8.1. Europe Parenteral Nutrition Market Overview

8.2. U.K.

8.2.1. U.K. Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

8.2.2. U.K. Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

8.2.3. U.K. Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

8.3. Germany

8.3.1. Germany Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

8.3.2. Germany Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

8.3.3. Germany Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

8.4. France

8.4.1. France Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

8.4.2. France Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

8.4.3. France Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

8.5. Spain

8.5.1. Spain Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

8.5.2. Spain Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

8.5.3. Spain Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

8.6.2. Rest of Europe Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

8.6.3. Rest of Europe Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Parenteral Nutrition Market By Country

9.1. Asia Pacific Parenteral Nutrition Market Overview

9.2. China

9.2.1. China Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

9.2.2. China Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

9.2.3. China Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

9.3. Japan

9.3.1. Japan Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

9.3.2. Japan Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

9.3.3. Japan Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

9.4. India

9.4.1. India Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

9.4.2. India Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

9.4.3. India Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

9.5. Australia

9.5.1. Australia Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

9.5.2. Australia Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

9.5.3. Australia Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

9.6. South Korea

9.6.1. South Korea Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

9.6.2. South Korea Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

9.6.3. South Korea Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

9.7.2. Rest of Asia-Pacific Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

9.7.3. Rest of Asia-Pacific Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Parenteral Nutrition Market By Country

10.1. Latin America Parenteral Nutrition Market Overview

10.2. Brazil

10.2.1. Brazil Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

10.2.2. Brazil Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

10.2.3. Brazil Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

10.3. Mexico

10.3.1. Mexico Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

10.3.2. Mexico Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

10.3.3. Mexico Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

10.4.2. Rest of Latin America Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

10.4.3. Rest of Latin America Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Parenteral Nutrition Market By Country 

11.1. Middle East & Africa Parenteral Nutrition Market Overview

11.2. GCC

11.2.1. GCC Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

11.2.2. GCC Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

11.2.3. GCC Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

11.3. South Africa

11.3.1. South Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

11.3.2. South Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

11.3.3. South Africa Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Nutrient Type, 2018-2030

11.4.2. Rest of Middle East & Africa Parenteral Nutrition Revenue (USD Million) and Forecast By Consumer, 2018-2030

11.4.3. Rest of Middle East & Africa Parenteral Nutrition Revenue (USD Million) and Forecast By End-use, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Parenteral Nutrition Market

12.1. Parenteral Nutrition Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Parenteral Nutrition Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Actavis, Inc.

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Million), 2021

13.1.3.2. Actavis, Inc. 2021 Parenteral Nutrition Business Regional Distribution

13.1.4. Product/Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. B. Braun Melsungen AG

13.3. Aculife (Nirlife)

13.4. Sichuan Kelun Pharmaceutical Co. Ltd.

13.5. Baxter International, Inc.

13.6. Hospira, Inc.

13.7. Grifols International S.A.

13.8. Otsuka Pharmaceutical Factory, Inc.

13.9. Fresenius Kabi AG

13.10. Vifor Pharma.

Frequently Asked Questions

What is the size of global parenteral nutrition market in 2021?

The estimated value of global parenteral nutrition market in 2021 was accounted to be USD 6,231 Million.

What is the CAGR of global parenteral nutrition market during forecast period of 2022 to 2030?

The projected CAGR parenteral nutrition market during the analysis period of 2022 to 2030 is 5.9%.

Which are the key players operating in the market?

The prominent players of the global parenteral nutrition market are Actavis, Inc., B. Braun Melsungen AG, Aculife (Nirlife), Sichuan Kelun Pharmaceutical Co. Ltd., Baxter International, Inc., Hospira, Inc., Grifols International S.A., Otsuka Pharmaceutical Factory, Inc., Fresenius Kabi AG, and Vifor Pharma.

Which region held the dominating position in the global parenteral nutrition market?

North America held the dominating parenteral nutrition market during the analysis period of 2022 to 2030.

Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?

Asia-Pacific region exhibited fastest growing CAGR for parenteral nutrition market during the analysis period of 2022 to 2030.

What are the current trends and dynamics in the global parenteral nutrition market?

Increasing prevalence of metabolic illnesses and rapidly expanding malnutrition across the globe drives the growth of global parenteral nutrition market.

By end-use segment, which sub-segment held the maximum share?

Based on end-use, hospitals segment is expected to hold the maximum share of the parenteral nutrition market.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 9000

Excel Datapack

US$ 2000

Why Acumen Research and Consulting

100%

Customer Satisfaction

24x7+

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date